RCG
CUE icon

Rock Creek Group’s Cue Biopharma CUE Stock Holding History

Rock Creek Group’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,190
Closed -$416K – 182
2021
Q2 		$416K Sell
1,190
-477
-29% -$185K 0.06% 99
2021
Q1 		$610K Sell
1,667
-1,667
-50% -$686K 0.1% 77
2020
Q4 		$1.25M Buy
3,334
+667
+25% +$267K 0.51% 53
2020
Q3 		$1.2M Buy
2,667
+2,074
+350% +$1.2M 0.62% 49
2020
Q2 		$436K Sell
593
-696
-54% -$504K 0.23% 88
2020
Q1 		$549K Buy
1,289
+39
+3% +$18.9K 0.3% 73
2019
Q4 		$595K Sell
1,250
-167
-12% -$52.5K 0.24% 87
2019
Q3 		$358K Sell
1,417
-240
-14% -$57.6K 0.17% 86
2019
Q2 		$447K Buy
+1,657
New +$412K 0.2% 84

Other funds holding CUE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return

Rock Creek Group's CUE Position: Q3 2021 in Review

Rock Creek Group sold out of Cue Biopharma (CUE) in Q3 2021, closing a stake of 1,190 shares — an estimated $416K sold.

Rock Creek Group first reported a position in CUE in Q2 2019 and held it in 9 quarters. The position peaked at $1.25M in Q4 2020. 89 funds tracked by Wall St. Rank hold CUE as of Q3 2021.

  • Rock Creek Group reported no remaining Cue Biopharma position as of Q3 2021 after selling out during the quarter.
  • Rock Creek Group sold 1,190 Cue Biopharma shares in Q3 2021, an estimated $416K.
  • Rock Creek Group first reported a position in Cue Biopharma in Q2 2019 and held it in 9 quarters.
  • Rock Creek Group's Cue Biopharma position peaked at $1.25M in Q4 2020.
  • 89 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2021.

Based on Rock Creek Group's 13F filing for Q3 2021, filed 12 Nov 2021.